These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 6138036

  • 61. 3'-Hydroxyesorubicin. Synthesis and antitumor activity.
    Priebe W, Neamati N, Perez-Soler R.
    J Antibiot (Tokyo); 1990 Jul; 43(7):838-46. PubMed ID: 2387778
    [Abstract] [Full Text] [Related]

  • 62. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
    Berners-Price SJ, Mirabelli CK, Johnson RK, Mattern MR, McCabe FL, Faucette LF, Sung CM, Mong SM, Sadler PJ, Crooke ST.
    Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
    Wright DG, Boosalis M, Malek K, Waraska K.
    Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
    [Abstract] [Full Text] [Related]

  • 68. Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin.
    Szekeres T, Fritzer M, Pillwein K, Felzmann T, Chiba P.
    Life Sci; 1992 Nov; 51(16):1309-15. PubMed ID: 1357518
    [Abstract] [Full Text] [Related]

  • 69. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation.
    Kharbanda SM, Sherman ML, Spriggs DR, Kufe DW.
    Cancer Res; 1988 Nov 01; 48(21):5965-8. PubMed ID: 2901907
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Nucleosides and nucleotides. 96. Synthesis and antitumor activity of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
    Minakawa N, Takeda T, Sasaki T, Matsuda A, Ueda T.
    J Med Chem; 1991 Feb 01; 34(2):778-86. PubMed ID: 1995901
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
    Prajda N, Hata Y, Abonyi M, Singhal RL, Weber G.
    Cancer Res; 1993 Dec 15; 53(24):5982-6. PubMed ID: 7903199
    [Abstract] [Full Text] [Related]

  • 75. Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells.
    Jayaram HN, Gharehbaghi K, Jayaram NH, Rieser J, Krohn K, Paull KD.
    Biochem Biophys Res Commun; 1992 Aug 14; 186(3):1600-6. PubMed ID: 1354960
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
    Franchetti P, Cappellacci L, Sheikha GA, Jayaram HN, Gurudutt VV, Sint T, Schneider BP, Jones WD, Goldstein BM, Perra G, De Montis A, Loi AG, La Colla P, Grifantini M.
    J Med Chem; 1997 May 23; 40(11):1731-7. PubMed ID: 9171883
    [Abstract] [Full Text] [Related]

  • 78. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
    Kato T, Suzumura Y, Fukushima M, Honda T, Nakanishi T, Noguchi T.
    Anticancer Res; 1988 May 23; 8(4):573-9. PubMed ID: 3178149
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.